Company Filing History:
1 out of 274 
1 out of 2,106 
Years Active: 1997
Title: Sophie Roy: Innovator in Anti-Tumor Assays
Introduction
Sophie Roy is a distinguished inventor based in Mount Royal, Canada. She has made significant contributions to the field of cancer research, particularly through her innovative patent related to anti-tumor agents. Her work focuses on developing methods to screen human tissue for neoplastic cells, which is crucial for early cancer detection and treatment.
Latest Patents
Sophie Roy holds a patent for an "Anti-tumor agent assay using PKR." This method involves screening human tissue for the presence of neoplastic cells by determining the activity of PKR, P58, and anti-P58 in test cells. The identification of candidate neoplastic cells is based on subnormal activity of these proteins. The patent also includes assay kits designed for carrying out this screening method, showcasing her commitment to advancing cancer diagnostics.
Career Highlights
Throughout her career, Sophie has worked at prestigious institutions such as McGill University and the University of Washington. Her research has been pivotal in enhancing our understanding of cancer biology and developing effective screening techniques.
Collaborations
Sophie Roy has collaborated with notable researchers, including Nahum Sonenberg and Michael G. Katze. These partnerships have enriched her work and contributed to the advancement of cancer research.
Conclusion
Sophie Roy's innovative contributions to anti-tumor assays highlight her role as a leading inventor in the field of cancer research. Her patent and collaborative efforts continue to pave the way for advancements in cancer diagnostics and treatment.